| Literature DB >> 25497876 |
Martin-Immanuel Bittner1, Anca-Ligia Grosu2, Thomas B Brunner3.
Abstract
IMRT has been suggested to reduce treatment-related toxicity in pancreatic cancer. We attempted to identify all IMRT-studies indexed in PubMed/Medline, comparing them with recent 3D-CRT trials. The predominant treatment-related toxicities, namely nausea/vomiting, diarrhoea and late GI toxicity, are significantly reduced with IMRT while there was no apparent difference for outcome measures.Entities:
Keywords: IMRT; Pancreatic cancer; Radiotherapy planning; Toxicity
Mesh:
Year: 2014 PMID: 25497876 DOI: 10.1016/j.radonc.2014.11.043
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280